Trial Profile
A Phase II Study of Navelbine (Vinorelbine) In Children With Recurrent Or Refractory Malignancies.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Mar 2011
Price :
$35
*
At a glance
- Drugs Vinorelbine (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- 11 Jan 2007 Status changed from in progress to completed
- 18 Sep 2005 New trial record.